Also known as: Dexcom
FiberSense received CE marking for its optical CGM system with up to 28-day wear, while LifeScan partnered with i-SENS to launch the OneTouch Vita CGM and appointed a new CEO. Senseonics' year-long Eversense 365 implantable CGM is also detailed.
Diabetes technology companies Dexcom, Insulet, and Sequel/Senseonics announced major product launches and algorithm updates. Dexcom is acquiring Nutrisense and launching an enhanced Stelo app, Insulet is rolling out an updated Omnipod 5 algorithm with lower glucose targets and Abbott compatibility, and Sequel/Senseonics have fully launched the Eversense 365 CGM with the twiist insulin delivery system in the U.S.
A UK trial found continuous glucose monitoring improved HbA1c and time in range for adults with type 2 diabetes using basal insulin. Dexcom is also awaiting a Medicare decision on broader CGM coverage for non-insulin users.
DexCom reported fourth-quarter 2025 revenue of US$1.26 billion and net income of US$267.3 million, with full-year sales of US$4.66 billion. The company reaffirmed 2026 revenue guidance of US$5.16–US$5.25 billion and targeted a non-GAAP operating margin of about 22–23%.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07681375 |
Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor |
ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT07681024 |
Global Long-term Outcomes and Real-World Evaluation of Dexcom Continuous Glucose Monitoring System (Dexcom GLOW) |
NOT_YET_RECRUITING | |
| NCT07507708 |
Insulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Control Enhanced by Prediction |
RECRUITING | NA |
| NCT07478211 |
Menstrual Cycle Mapping While Using Closed-Loop Insulin Delivery |
ACTIVE_NOT_RECRUITING | |
| NCT07212790 |
REAL-Fam Feasibility Study for Youth Diabetes Management |
ACTIVE_NOT_RECRUITING | NA |
| NCT07087340 |
Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop-Genesis |
COMPLETED | NA |
| NCT06939413 |
Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations |
ACTIVE_NOT_RECRUITING | NA |
| NCT06841796 |
The YMCA Healthy Lifestyle Program for Prediabetes |
ACTIVE_NOT_RECRUITING | NA |
| NCT06601166 |
CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin |
ACTIVE_NOT_RECRUITING | NA |
| NCT06050265 |
Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome |
ACTIVE_NOT_RECRUITING | NA |
